D. Boral Capital Reiterates Buy Rating for AVITA Medical (NASDAQ:RCEL)
AVITA Medical (NASDAQ:RCEL – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at D. Boral Capital in a research note issued on Friday,Benzinga reports. They currently have a $19.00 target price on the stock. D. Boral Capital’s price objective indicates a potential upside of 210.97% from the stock’s current price. AVITA […]
AVITA Medical (NASDAQ:RCEL – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at D. Boral Capital in a research note issued on Friday,Benzinga reports. They currently have a $19.00 target price on the stock. D. Boral Capital’s price objective indicates a potential upside of 210.97% from the stock’s current price. AVITA […]
